{ "items": [ "\n\n
\n \n 5 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Gyrd-Hansen\n \n \n\n \n\n\n
\n \n\n \n \n \nMads Gyrd-Hansen\u2019s group investigates how the deubiquitinase CYLD, which moderates innate immune responses, is itself regulated.
\n \n\n\n \n 1 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Mehdipour\n \n \n\n \n\n\n
\n \n\n \n \n \nOur new Leadership Fellow launches a research group in cancer epigenetics and epitranscriptomics.
\n \n\n\n \n 30 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Schuster-B\u00f6ckler\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Benjamin Schuster-B\u00f6ckler will join the Turing network for 2021-2022 to further his research in cancer big data.
\n \n\n\n \n 28 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Goding\n \n \n\n \n\n\n
\n \n\n \n \n \nLudwig Oxford\u2019s Professor Colin Goding and Sao Paulo\u2019s Professor Silvya Stuchi Maria-Engler show that TOP1 is involved in melanoma progression and adaptive resistance to treatment.
\n \n\n\n \n 21 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Barnes\n \n \n\n \n\n\n
\n \n\n \n \n \nLudwig Oxford welcomes Ellie Barnes to our community, which she has joined as a Ludwig Adjunct Scholar.
\n \n\n\n \n 3 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Van den Eynde\n \n \n\n \n\n\n
\n \n\n \n \n \nA new publication from Benoit Van den Eynde's group has shown that a viral vector cancer vaccine generates effective anti-tumour immune responses and, in combination with immunotherapy, decreases tumour size and increases survival rates in mouse models.
\n \n\n\n \n 1 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Barnes\n \n \n \n \n Song\n \n \n\n \n\n\n
\n \n\n \n \n \nTAPS technology has been optimised for mapping DNA methylation on circulating cell-free DNA.
\n \n\n\n \n 9 August 2021\n \n
\n\n \n\n \n\n \n \n \n \n Boccellato\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nClaudia Zagami from the Boccellato lab was selected to give a talk on 3D tissue models for studying disease.
\n \n\n\n \n 22 July 2021\n \n
\n\n \n\n \n\n \n \n \n \n Kriaucionis\n \n \n \n \n Lu\n \n \n \n \n Public Engagement\n \n \n \n \n Van den Eynde\n \n \n\n \n\n\n
\n \n\n \n \n \nThree Ludwig Oxford volunteers participate at the 2021 Oncology UNIQ summer school
\n \n\n\n \n 30 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n Constantinescu\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Stefan Constantinescu joins Ludwig Oxford to expand his research programme in cancer epigenetics.
\n \n\n\n \n 17 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n Goding\n \n \n\n \n\n\n
\n \n\n \n \n \nA study from Professor Colin Goding\u2019s group gives insight into the function of the BRN2 transcription factor in promoting melanoma initiation and metastasis.
\n \n\n\n \n 9 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n Lu\n \n \n \n \n Rittscher\n \n \n\n \n\n\n
\n \n\n \n \n \nClinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett\u2019s oesophagus and so determine patients most at risk of developing cancer.
\n \n\n\n \n 8 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n Shi\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Yang Shi\u2019s group demonstrates that combining drugs targeting epigenetic and metabolic pathways can overcome the arrest of white blood cell differentiation in this blood cancer.
\n \n\n\n \n 4 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n Goding\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Colin Goding\u2019s lab collaborate with colleagues in Germany to develop a new method to measure stem cell dormancy.
\n \n\n\n \n 2 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n Lu\n \n \n\n \n\n\n
\n \n\n \n \n \nLudwig Oxford\u2019s Dr Linna Zhou will investigate the role of the nervous system in cancer progression using engineered gastrointestinal tissues.
\n \n\n\n \n 26 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n Rittscher\n \n \n\n \n\n\n
\n \n\n \n \n \nA multidisciplinary team, comprising Ludwig Oxford\u2019s Professor Jens Rittscher with Andrea Chatrian, Dr Richard Colling, Professor Clare Verrill and colleagues, develops an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.
\n \n\n\n \n 25 May 2021\n \n
\n\n \n \n \n\n \n \n \nLudwig Oxford are delighted to welcome this acclaimed scientist to the Branch and the Oxford community.
\n \n\n\n \n 7 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n Rittscher\n \n \n \n \n Shi\n \n \n \n \n Song\n \n \n\n \n\n\n
\n \n\n \n \n \nOn 28-29th April 2021, we heard the latest developments from international leaders in these fields from the University of Oxford, Ludwig Cancer Research and beyond.
\n \n\n\n \n 4 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n Boccellato\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Francesco Boccellato investigates how growth factors influence differentiation and patterning in human gastric glands.
\n \n\n\n \n 28 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n Song\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Chunxiao Song\u2019s team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.
\n \n\n